COVID-19
Additional Info
COVID-19 Vaccine Safety
The COVID-19 vaccines reduce the risks of severe illness, hospitalizations, and deaths.1, 2, 3, 4, 5, 6 The process to develop the vaccines was systematic with each United States vaccine undergoing rigorous clinical trials.
For full approval of a new drug or vaccine, the FDA requires extensive data on safety and effectiveness, an inspection of manufacturing facilities, and a comprehensive review of all clinical and “real-world” use.
COVID-19 vaccinations are currently included in the recommended vaccination schedule for adults per the CDC.7
It is safe and acceptable to receive multiple immunizations, such as the COVID-19, Influenza, and Respiratory Syncytial Virus (RSV) vaccines, during the same vaccination appointment.
COVID-19 Vaccine Benefits
Receiving a COVID-19 vaccine is a safe way to build protection against the disease. COVID-19 can have serious, life-threatening complications, and there is no way to know how COVID-19 will affect you. COVID-19 vaccinations provide antibodies to equip your body to fight the virus without having to experience sickness or putting yourself at increased risk of severe illness.
COVID-19 vaccines remain our single most important tool to reduce the risk of serious illness, hospitalization, and death.9
An annual COVID-19 immunization restores the protection of vaccines that wanes over time. Updated vaccines have been designed to protect against the latest transmittable variant.
The benefits of COVID-19 vaccination continue to outweigh any potential risks. Serious reactions after COVID-19 vaccination are rare. In one study, the risk of cardiac complications, including myocarditis, in males 12-17 years old was 1.8-5.6 times higher after COVID-19 infection than after COVID-19 vaccination.10
Adverse heart events (heart attack, strokes, etc. including myocarditis) were significantly lower after infection among vaccinated individuals compared to unvaccinated individuals.10
The COVID-19 vaccine not only has individual benefits, but there are benefits for the overall workplace. The more employees who are updated with their vaccination, the more protected the workforce. Keeping the workforce healthy will contribute to essential work continuing (e.g., delivery of patient care).
Not only does the vaccine help prevent infection, but it can reduce the severity of symptoms, viral burden, and transmission risk if infected. Vaccination may prevent long COVID-19 symptoms. Clearly, reducing the severity of infection through vaccination lowers the risk of developing long COVID-19.
With the current viral respiratory season, individuals are at risk for contracting COVID-19, Influenza, and/or Respiratory Syncytial Virus (RSV). Vaccines against these viruses can be given in any order or at the same time. There is no interval requirement to receive the vaccines to protect against these viruses.
If you think you have any type of respiratory infection, you should get tested for all three viruses. Click here for more information on Influenza or RSV.
COVID-19 Vaccine Effectiveness
Everyone 6 months and older is recommended to receive a single 2024-2025 COVID-19 vaccine (either Moderna, Pfizer, or Novavax).8
If you have never been vaccinated, you should receive one dose of this year’s Moderna or Pfizer COVID-19 vaccine OR 2 doses of this year’s Novavax vaccine.
If you have been previously vaccinated and it has been at least 2 months since the last vaccine, you should receive one dose of any 2024-2025 COVID-19 vaccine (Moderna, Pfizer, or Novavax).
If you have never received any COVID-19 vaccine and it is decided to get a Novavax, you would need two (2) doses of the 2024-2025 Novavax COVID-19 vaccine to be considered up to date.
Individuals 65 years and older and those who are moderately or severely immunocompromised should receive a second dose of 2024-2025 COVID-19 vaccine 6 months after their first dose.
Getting a COVID-19 vaccine after you recover from COVID-19 infection provides added protection against severe disease in the future. For anyone who has been recently infected with COVID-19, their next dose may be delayed 3 months from when their symptoms started or the date of their positive test if they did not have symptoms.
As of September 3, 2023, J&J/Janssen COVID-19 vaccine has expired and is no longer available for use in the United States.
COVID-19 Vaccine Availability and Getting the Shot
The COVID-19 vaccine supply is available at doctors’ offices, retail pharmacies, hospitals, and clinics. Be sure to make an appointment to receive the vaccinations.
Vaccines are now covered by insurance, including Medicare and Medicaid. Additional costs would be dependent on your health insurance.
Before receiving the vaccine, you will be screened for contraindications.
Though rare, allergic reactions, including anaphylaxis, have been reported. If this occurs, vaccination providers can effectively and immediately treat anaphylaxis. If you have concerns about your medical condition(s) and receiving the vaccine, consult with your healthcare provider.
-
Rosenblum HG, Gee J, Liu R, et al. Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe. Lancet. March 7, 2022. DOI:https://doi.org/10.1016/S1473-3099(22)00054-8.
Menni C, May A, Polidori L, Louca P, Wolf J, Capdevila J, et al. COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study. Lancet. 2022;22(7):P1002-1010. Available at: https://doi.org/10.1016/S1473-3099(22)00146-3.
Hause AM, Baggs J, Marquez P, Abara WE, Baumblatt J, Blanc PG, Su JR, et al. Safety Monitoring of COVID-19 mRNA Vaccine Second Booster Doses Among Adults Aged ≥50 Years — United States, March 29, 2022–July 10, 2022. MMWR Morb Mortal Wkly Rep. 2022 Jul 29;71(30);971–976. Available at: https://www.cdc.gov/mmwr/volumes/71/wr/mm7130a4.htm?s_cid=mm7130a4_w.
Hause AM, Baggs J, Marquez P, Abara WE, Baumblatt JG, Thompson D, Su JR, Myers TR, Gee J, Shimabukuro TT, Shay DK. Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years with Presumed Immunocompromise Status — United States, January 12, 2022–March 28, 2022. MMWR Morb Mortal Wkly Rep. 2022 Jul 15; 71(28);899-903. Available at: https://www.cdc.gov/mmwr/volumes/71/wr/mm7128a3.htm?s_cid=mm7128a3_w.
Hause AM, Baggs J, Marquez P, Myers TR, Su JR, Blanc PG, Gwira Baumblatt JA, et al. Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults - United States, September 22, 2021-February 6, 2022. MMWR Morb Mortal Wkly Rep. 2022 Feb 18;71(7):249-254. Available at: http://dx.doi.org/10.15585/mmwr.mm7107e1.
Singh A, Khillan R, Mishra Y, Khurana S. The safety profile of COVID-19 vaccinations in the United States. Am J Infection Control. 2022;50(1):15-19. Available at: https://www.ajicjournal.org/article/S0196-6553(21)00684-2/fulltext.
Murthy N, Wodi AP, McNally V, Cineas S, Ault K. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2023. MMWR Morb Mortal Wkly Rep. 2023;72:141–144. DOI: http://dx.doi.org/10.15585/mmwr.mm7206a2.
Centers for Disease Control and Prevention (CDC). Staying Up to Date with COVID-19 Vaccines. October 3, 2024. Available at: https://www.cdc.gov/covid/vaccines/stay-up-to-date.html.
Centers for Disease Control and Prevention (CDC). New COVID-19 Vaccine Effectiveness Data Showcase Protection Gained by 3rd and 4th Doses. July 15, 2022. Available at: https://www.cdc.gov/media/releases/2022/s0715-COVID-VE.html.
Block JP, Boehmer TK, Forrest CB, et al. Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination — PCORnet, United States, January 2021–January 2022. MMWR Morb Mortal Wkly Rep. 2022;71:517-523. DOI: http://dx.doi.org/10.15585/mmwr.mm7114e1.
Updated November 21 , 2024 ACOEM continues to follow the latest information related to COVID-19 and will update as necessary.
COVID-19 Frequently Asked Questions
For additional questions, consult with your healthcare provider.
Updated November 21, 2024
-
For many people, the benefits of preventing a COVID-19 infection outweigh the risks of the vaccine. The vaccine protects you from getting COVID-19 and is considered a safe way to build protection against the disease. By getting vaccinated, you are helping protect yourself, your family and friends. COVID-19 could have some side effects or complications. There is no way to know how COVID-19 will affect you or your loved ones. If you are exposed to the virus, the vaccine may prevent serious illness and death.
-
It is recommended that individuals 65 years and older and those who are moderately or severely immunocompromised receive a second dose of 2024-2025 COVID-19 vaccine 6 months after their first dose.
-
For anyone who has been infected with COVID-19, their next dose may be delayed 3 months from when symptoms started or, if they did not have symptoms, when they received a positive test. Consult with your healthcare provider if you have any questions about the timing of your vaccination.
-
No. None of the COVID-19 vaccines authorized for use in the U.S. contain the live virus that causes COVID-19.
-
No. Viral tests such as PCR used to diagnose COVID-19 check samples from the respiratory system for the presence of the virus that causes COVID-19. Since the vaccines do not contain the live virus, they will not affect your PCR test result. However, it typically takes a few weeks for the body to build immunity after vaccination. Therefore, it is possible to test positive if you were infected with the virus that causes COVID-19 just before or just after vaccination.
It is possible you may test positive on some antibody tests if your body develops an immune response. Positive antibody tests can indicate you had a previous infection or vaccination and that you may have some level of protection against the virus. Antibody (Ab) testing is used in highly specialized situations (e.g., studies and surveillance) and should not be utilized to inform vaccination for employees.
-
Yes. Even if you have already recovered from COVID-19, it is possible that you could be infected with the virus that causes COVID-19 again. Receiving the vaccine when you have already had COVID-19 significantly enhances your immune protection and further reduces your risk of reinfection. For anyone who has been infected with COVID-19, their next dose may be delayed 3 months from when symptoms started or, if they did not have symptoms, when they received a positive test. Consult your healthcare provider if you have any questions about the timing of your vaccination.
-
No. You should wait to be vaccinated to avoid potentially exposing healthcare personnel and others during the vaccination visit. Stay home and away from others (including people you live with who are not sick) if you have a respiratory virus. You can go back to your normal activities when, for at least 24 hours, both are true: your symptoms are getting better overall, and you have not had a fever (and are not using fever-reducing medication). When you go back to your normal activities, take added precaution over the next 5 days.
-
COVID-19 vaccines help prevent severe illness, hospitalization, and death. Unvaccinated individuals are more likely to get COVID-19 and much more likely to be hospitalized and die from COVID-19, compared to individuals who are up to date with their COVID-19 vaccinations.
-
There is no recommended waiting period between getting a COVID-19 vaccine and other vaccines. You can get a COVID-19 vaccine and other vaccines, including a flu vaccine, at the same visit.
-
Yes. There is currently no evidence that antibodies formed from COVID-19 vaccination cause any problem with pregnancy, including the development of the placenta. Also, people who are trying to become pregnant now or who plan to try in the future may receive the COVID-19 vaccine. There is no evidence that fertility problems are a side effect of any of the COVID-19 vaccines. See ACOG’s practice advisory and CDC's recommendations on COVID vaccination for pregnant women.
-
Yes. As with many vaccines, there may be mild side effects (pain/swelling in the arm where you received the shot, fever, chills, fatigue, and headache). Side effects should only last a few days. There are rare side effects that have occurred, but at the current time, there are no common, severe side effects that have been reported despite millions of vaccine administrations.
-
You should be able to return to your workplace after receiving the vaccine. Most people who get the vaccine have mild or no side effects. For those who have side effects, they may uncommonly affect your ability to do some daily activities. If you experience a fever after vaccination, you may need to stay home from work and may need further evaluation.
-
Safety data have been collected for years for all authorized vaccines. It is unusual for vaccine side effects to appear more than 6 weeks after vaccination. Vaccines do not generally have long-term side effects and there is no reason to believe the COVID-19 vaccine will be an exception. Side effects and adverse events can be reported in the Vaccine Adverse Event Reporting System (VAERS).
-
Talk to a healthcare provider about taking over-the-counter medicine, such as ibuprofen, acetaminophen, aspirin (only for people ages 18 years or older), or antihistamines for any pain and discomfort experienced after getting vaccinated.
-
Vaccines are now covered by insurance, including Medicare and Medicaid. Additional costs would be dependent on your personal health insurance.
-
Check with your employer to see if they have any rules that apply to you.
-
Yes. The U.S. Food and Drug Administration (FDA) approves a vaccine for use only if there are enough data to suggest that it is safe and effective; this is after clinical trials have been conducted with thousands of people of various ages, races, and ethnicities and when the benefits outweigh risks. Every study and every phase of every trial was carefully reviewed and approved by a safety board and the FDA. The process was transparent and rigorous, with continual oversight and expert approval.
The FDA will continue to monitor and oversee vaccine production to ensure all safety protocols are followed. The FDA and CDC also collect and analyze information from reports of any side effects that may occur after a vaccine has been licensed.
-
Studies are ongoing and experts are working to learn more about both natural immunity and vaccine-induced immunity. Research shows that FDA-authorized or approved vaccines are effective at reducing the risk of severe COVID-19 disease. Getting COVID-19 also provides infection-induced immunity. The length of protection is unclear for either vaccination or infection-induced immunity, although there is consistent evidence suggesting that immunity may decline with time. Protection may be the greatest from 2-6 weeks after vaccination. After 2-3 months, protection against infection wanes significantly. However, protection against severe disease lasts much longer. An annual COVID-19 immunization restores the protection of vaccines that wanes over time. Updated vaccines have been designed to protect against the latest variants circulating.
-
No vaccine is 100% effective against preventing infection. But, we do know that the COVID-19 vaccine is highly effective against serious illness, hospitalizations, and deaths. Severe outcomes and deaths are increasingly only being experienced in either the unvaccinated and/or severely immunocompromised individuals.
-
Fully vaccinated individuals may participate in many activities that they participated in prior to the pandemic but for some of these activities, they may have to resume masking based on state and local ordinances. There may be masking recommendations for all individuals based on employer policies or state and local ordinances.
-
The American College of Obstetrics and Gynecology. Practice Advisory: COVID-19 Vaccination Considerations for Obstetric–Gynecologic Care. October 16, 2024. Available at: https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2020/12/covid-19-vaccination-considerations-for-obstetric-gynecologic-care.
Centers for Disease Control and Prevention. COVID-19 Vaccine Frequently Asked Questions. August 30, 2024. Available at: https://www.cdc.gov/covid/vaccines/faq.html?CDC_AAref_Val=https://www.cdc.gov/coronavirus/2019-ncov/vaccines/faq.html.
Centers for Disease Control and Prevention (CDC). Staying Up to Date with COVID-19 Vaccines. October 3, 2024. Available at: https://www.cdc.gov/covid/vaccines/stay-up-to-date.html?CDC_AAref_Val=https://www.cdc.gov/coronavirus/2019-ncov/vaccines/stay-up-to-date.html.
Centers for Disease Control and Prevention (CDC). Use of COVID-19 Vaccines in the United States - Interim Clinical Considerations. October 31, 2024. Available at: https://www.cdc.gov/vaccines/covid-19/clinical-considerations/covid-19-vaccines-us.html.
U.S. Food & Drug Administration. FDA Approves First COVID-19 Vaccine. August 23, 2021. Available at: https://www.fda.gov/news-events/press-announcements/fda-approves-first-covid-19-vaccine.
Other Vaccine Information
-
Influenza
Guidance on influenza vaccine.
-
Mpox (Monkeypox)
Guidance for the prevention and treatment of Mpox.
-
Travel
Guidance on what vaccines are necessary for employees who travel.
-
Vaccine Hesitancy
Resources to address vaccine hesitancy and improve vaccine communication.